IPP Bureau
Codis expands UK manufacturing with groundbreaking spray dryer
By IPP Bureau - March 10, 2026
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
UK pushes space-made medicines from orbit to patients with new support package
By IPP Bureau - March 10, 2026
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Lifecore Biomedical teams up with Indomo to advance at-home acne therapy
By IPP Bureau - March 10, 2026
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
Hopewell Therapeutics sublicenses breakthrough LNP technology to Foxcroft for cancer vaccine development
By IPP Bureau - March 10, 2026
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
Frontage Laboratories expands China presence with Teddy Lab acquisition
By IPP Bureau - March 10, 2026
Mosaic Clinical Technologies’ AI breakthrough earns FDA “Breakthrough Device” designation
By IPP Bureau - March 10, 2026
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
GAIA and Daiichi Sankyo Europe join forces to launch groundbreaking digital therapeutic for heart health
By IPP Bureau - March 10, 2026
Germany will be the first launch market
KIMS Hospitals makes bold entry into Bengaluru with two new super-speciality units
By IPP Bureau - March 10, 2026
The hospitals house over 25 super-speciality centres and Centres of Excellence in Cardiology, Neurology, Oncology, Paediatrics, Orthopaedics, ENT, Obstetrics and Gynaecology, General Surgery, Internal Medicine, Critical Care, and Chronic Disease Management
Novo Nordisk strikes deal with Hims & Hers, expands access to Ozempic & Wegovy in US
By IPP Bureau - March 10, 2026
Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
Neuland to launch commercial peptide facility in Hyderabad as global capacity tightens
By IPP Bureau - March 10, 2026
The first of four planned modules at the new plant is expected to come online by summer 2026
Lilly expands affordable access to diabetes & obesity medicines under new medicare programme
By IPP Bureau - March 10, 2026
Starting January 1, 2027, Lilly’s Zepbound (tirzepatide), Mounjaro (tirzepatide), and orforglipron, if approved, will be available through participating Medicare Part D plans
Mumbai doctors perform India’s first robotic surgery to fix rare uterine defect in 23 year old
By IPP Bureau - March 10, 2026
Doctors recommended a robotic Strassmann Metroplasty, a reconstructive surgery that joins the two halves of the uterus into a single cavity capable of supporting pregnancy
Avio Smart teams up with Huwel Lifesciences to roll out next-gen molecular diagnostics in India
By IPP Bureau - March 10, 2026
Huwel’s diagnostic solutions leverage open RT-PCR system
